These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 25445182)
1. Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Praet J; Guglielmetti C; Berneman Z; Van der Linden A; Ponsaerts P Neurosci Biobehav Rev; 2014 Nov; 47():485-505. PubMed ID: 25445182 [TBL] [Abstract][Full Text] [Related]
2. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. Acs P; Komoly S Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy. Orije J; Kara F; Guglielmetti C; Praet J; Van der Linden A; Ponsaerts P; Verhoye M Neuroimage; 2015 Jul; 114():128-35. PubMed ID: 25871629 [TBL] [Abstract][Full Text] [Related]
4. Neuronal expression of the transcription factor serum response factor modulates myelination in a mouse multiple sclerosis model. Anastasiadou S; Liebenehm S; Sinske D; Meyer zu Reckendorf C; Moepps B; Nordheim A; Knöll B Glia; 2015 Jun; 63(6):958-76. PubMed ID: 25639799 [TBL] [Abstract][Full Text] [Related]
5. The cuprizone animal model: new insights into an old story. Kipp M; Clarner T; Dang J; Copray S; Beyer C Acta Neuropathol; 2009 Dec; 118(6):723-36. PubMed ID: 19763593 [TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model. Nunes AK; Rapôso C; de Oliveira WH; Thomé R; Verinaud L; Tovar-Moll F; Peixoto CA Exp Neurol; 2016 Jan; 275 Pt 1():143-53. PubMed ID: 26515692 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study. Ghaiad HR; Nooh MM; El-Sawalhi MM; Shaheen AA Mol Neurobiol; 2017 Jul; 54(5):3219-3229. PubMed ID: 27067589 [TBL] [Abstract][Full Text] [Related]
8. The cuprizone model for demyelination. Torkildsen O; Brunborg LA; Myhr KM; Bø L Acta Neurol Scand Suppl; 2008; 188():72-6. PubMed ID: 18439226 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model. Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839 [TBL] [Abstract][Full Text] [Related]
10. 17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis. Ragerdi Kashani I; Hedayatpour A; Pasbakhsh P; Kafami L; Atlasi N; Pirhajati Mahabadi V; Mamoudi R; Baazm M Acta Med Iran; 2012; 50(12):789-97. PubMed ID: 23456519 [TBL] [Abstract][Full Text] [Related]
11. The cuprizone model: regional heterogeneity of pathology. Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688 [TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination. Lindner M; Trebst C; Heine S; Skripuletz T; Koutsoudaki PN; Stangel M Glia; 2008 Aug; 56(10):1104-13. PubMed ID: 18442092 [TBL] [Abstract][Full Text] [Related]
14. Changes in neurosteroidogenesis during demyelination and remyelination in cuprizone-treated mice. Leicaj ML; Pasquini LA; Lima A; Gonzalez Deniselle MC; Pasquini JM; De Nicola AF; Garay LI J Neuroendocrinol; 2018 Nov; 30(11):e12649. PubMed ID: 30303567 [TBL] [Abstract][Full Text] [Related]
15. Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model. Nellessen A; Nyamoya S; Zendedel A; Slowik A; Wruck C; Beyer C; Fragoulis A; Clarner T Metab Brain Dis; 2020 Feb; 35(2):353-362. PubMed ID: 31529356 [TBL] [Abstract][Full Text] [Related]
16. Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice. Hoffmann K; Lindner M; Gröticke I; Stangel M; Löscher W Exp Neurol; 2008 Apr; 210(2):308-21. PubMed ID: 18096162 [TBL] [Abstract][Full Text] [Related]
17. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Komoly S Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397 [TBL] [Abstract][Full Text] [Related]
18. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia. Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876 [TBL] [Abstract][Full Text] [Related]
19. Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model. Tahmasebi F; Barati S; Kashani IR Neuropeptides; 2021 Oct; 89():102179. PubMed ID: 34274854 [TBL] [Abstract][Full Text] [Related]
20. Cuprizone Administration Alters the Iron Metabolism in the Mouse Model of Multiple Sclerosis. Varga E; Pandur E; Abrahám H; Horváth A; Ács P; Komoly S; Miseta A; Sipos K Cell Mol Neurobiol; 2018 Jul; 38(5):1081-1097. PubMed ID: 29464444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]